Effects of high-density lipoproteins on intracellular pH and proliferation of human vascular endothelial cells

Atherosclerosis

Volumn 123, Issue 1-2, 1996, Pages 73-82

  Tamagaki, Toshiyuki ^a   Sawada, Shohei ^a   Imamura, Hitoshi ^a   Tada, Yuusuke ^a   Yamasaki, Seiki ^a   Toratani, Akihisa ^a   Sato, Toshiyuki ^a   Komatsu, Sumio ^a   Akamatsu, Naoaki ^a   Yamagami, Mashahito ^a   Kobayashi, Kyoichiro ^a   Kato, Kazuharu ^a   Yamamoto, Katsumi ^a   Shirai, Kaoru ^a   Yamada, Keizo ^a   Higaki, Tadashi ^a   Nakagawa, Katsumi ^a   Tsuji, Hajime ^a   Nakagawa, Masao ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

Atherosclerosis; HDL; Human vascular endothelial cell; Intracellular pH; Prostacyclin

Indexed keywords

AMILORIDE; ANTIMYCIN A1; CALCIMYCIN; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; OLIGOMYCIN; PROSTAGLANDIN;

ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CALCIUM CELL LEVEL; CELL PH; CELL PROLIFERATION; CONTROLLED STUDY; CORONARY ARTERY DISEASE; HUMAN; HUMAN CELL; PRIORITY JOURNAL; RISK FACTOR; VASCULAR ENDOTHELIUM;

EID: 0029994882     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/0021-9150(95)05774-9     Document Type: Article

References (33)

1. Molski TFP, Naccache PH, Volpi M, Wolpert LM, Sha'afi RI. Specific modulation of the intracellular pH of rabbit neutrophils by chemotactic factors. Biochem Biophys Res Commun 1980;94:508.
2. Segal AW, Geisow M, Garcia R, Harper A, Miller R. The respiratory burst of phagocytic cells is associated with a rise in vacuolar pH. Nature 1981;290:406.
3. Simchowitz L. Intracellular pH modulates the generation of superoxide radicals by human neutrophils. J Clin Invest 1985;76:1079.
4. + exchange in human neutrophils: mechanism of activation by chemotactic factors. Biochem Biophys Res Commun 1984;122:755.
5. Royal DS, Yvonne WB, George HD. Role of intracellular pH in the axolemma and myelin induced proliferation of Schwann cells. J Neurochem 1989;52:1576.
6. Wounter HM. Effects of growth factors on intracellular pH regulation. Annu Rev Physiol 1986;48:363.
7. Philip MC, Johnson WJ, Rothblat GH. Mechanisms and consequences of cellular cholesterol exchange and transfer. Biochim Biophys Acta 1987;906:223.
8. 2+ and cyclic nucleotides. Blood Vessels 1985;16:245.
9. Weibel ER, Palade GE. New cytoplasmic components in arterial endothelia. Cell Biol 1964;23:101.
10. 2+ in lymphocytes. J Cell Biol 1982;95:189.
11. Thomas JA, Buchsbaum RN, Zimniak A, Racker E. Intracellular pH measurements in Ehrlich ascites tumour cells utilizing spectroscopic probes generated in situ. Biochemistry 1979;18:2210.
12. Toyoda T, Nakagawa M, Maeda Y, Niwa I, Tsuji H, Rin K, Osamura K, Kitani T, Ijichi H. Effect of Ca antagonist on vascular prostacyclin generation. J Pharmacol Ther 1983;11:63.
13. Burgess GM, McKinney JS, Fabiato A, Leslie BA, Putney JW Jr. Calcium pools in saponin-permeabilized guinea pig hepatocytes. J Biol Chem 1983;258:15336.
14. + exchange in cultured bovine aortic endothelial cells stimulated by extracellular ATP. Biochim Biophys Acta 1989;1013:152-158.
15. 2+ influx in platelets. Biochim Biophys Acta 1988;940:141.
16. Gillies RJ, Zaguilan RM. Regulation of intracellular pH in BALB/c 3T3 cells. J Biol Chem 1991;266:1551.
17. + exchange in rat pituitary cells. Biochem J 1987;242:411.
18. Levin EG, Marzec U, Underson J, Harker LA. Thrombin stimulates tissue plasminogen activator release from cultured human endothelial cells. J Clin Invest 1984;74:1988.
19. Meng HP, Michael JB, Pierce GN. Effect of platelet-activating factor (PAF) on sodium calcium exchange in cardiac sarcolemmal vesicles. Mol Cell Biochem 1990;92:45.
20. + antiport activation by endothelin in human skin fibroblasts. FEBS Lett 1989;256:38.
21. 2 synthesis in human umbilical vein endothelial cells. J Biol Chem 1993;268:839.
22. 2 from human synovial fluid in rheumatoid arthritis. Biochem J 1989;105:395.
23. 2. Biochim Biophys Acta 1991;1083:80.
24. Ulrich A, Schlessinger J. Signal transduction by receptors with tyrosine kinase activity. Cell 1990;61:203.
25. Tall AR, Small DM. Body cholesterol removal: role of plasma high-density lipoproteins. Adv Lipid Res 1980;17:1.
26. Badimon JJ, Badimon L, Galvez A, Dische R, Fuster V. High density lipoprotein plasma fractions inhibit aortic fatty streaks in cholesterol-fed rabbits. Lab Invest 1989;60:455.
27. Ross R. The pathogenesis of atherosclerosis - an update. N Engl J Med 1986;31:488.
28. 2+ -catalyzed oxidation of human low density lipoprotein. FEBS Lett 1989;257:435.
29. Yui Y, Aoyama T, Morishima H, Takahashi M, Takatsu Y, Kawai C. Serum prostacyclin stabilizing factor is identical to apoprotein, A1. J Clin Invest 1988;82:803.
30. Fleisher NL, Tall AR, Witte LD, Miller RW, Cannon PJ. Stimulation of arterial endothelial cell prostacyclin synthesis by high density lipoproteins. 1982;257:6653.
31. 2 production by Ca antagonists. J Kyoto Pref Univ Med 1986;95:205.
32. 2+ release from the storage sites of human umbilical vein endothelial cells with references to the prostacyclin generation. J Thromb Hemost 1990;1:321.
33. Weksler BB, Ley CW, Jaffe EA. Stimulation of endothelial cell prostacyclin production by thrombin trypsin and the ionophore A23187. J Clin Invest 1978;62:923.